HCA
ABVX icon

Harbour Capital Advisors’s Abivax ABVX Stock Holding History

Harbour Capital Advisors’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$305K Buy
+3,085
New +$372K 0.06% 250

Other funds holding ABVX

TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
VFP
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
WPA
West Paces Advisors Atlanta, Georgia $586M AUM 14.12% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

Harbour Capital Advisors's ABVX Position: Q3 2026 in Review

Harbour Capital Advisors opened a new position in Abivax (ABVX) in Q3 2026: 3,085 shares worth $305K. The stake represents 0.06% of the portfolio and ranks #250 among its holdings.

13 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Harbour Capital Advisors held 3,085 shares of Abivax worth $305K as of Q3 2026.
  • Abivax was a new Harbour Capital Advisors position in Q3 2026.
  • Abivax made up 0.06% of Harbour Capital Advisors's portfolio in Q3 2026, its #250 holding.
  • 13 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Harbour Capital Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.